Vimpat Oral Solution 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Vimpat: Oral solution (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Vimpat 10mg/ml Soln

What is this Medicine?

LACOSAMIDE (la KOE sa mide) is used to control seizures caused by certain types of epilepsy.

CVS Pharmacy Patient Statistics for Vimpat: Oral solution(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Vimpat 10mg/ml Solution

NDC: 001315410
  • Prescription Required
  • Federally Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Partial Seizures

Storage Information
Use within 7 weeks of first opening the bottle
Discard unused portion. Do not store for later use.
Do not freeze
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Vimpat 10mg/ml Solution

Reported Side Effects for Vimpat 10mg/ml Solution

Heart Block Incidence:
0.4-0.5%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Beat Incidence:
0.5%*
Severity: SEVERE
Onset: EARLY
Irregular Heart Rate Incidence:
0.5%*
Severity: SEVERE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
0.7%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
1.2%*
Severity: MILD
Onset: EARLY
Itching Incidence:
2.0-3.0%*
Severity: MILD
Onset: RAPID
Fast Eye Movements Incidence:
2.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Depression Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Confusion Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: EARLY
Blurred Vision Incidence:
2.0-16.0%*
Severity: MODERATE
Onset: EARLY
Weakness Incidence:
2.0-4.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
4.0-12.0%*
Severity: MILD
Onset: EARLY
Incoordination Incidence:
4.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
5.0-8.0%*
Severity: MILD
Onset: EARLY
Double Vision Incidence:
6.0-16.0%*
Severity: MILD
Onset: EARLY
Elated Mood Incidence:
6.0-25.0%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
6.0-16.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0-17.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
7.0-15.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
11.0-14.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
16.0-53.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More